Glaxo offers WHO 50 million pandemic vaccines

May 19, 2009

(AP) -- Drug giant GlaxoSmithKline said it has offered to donate 50 million doses of a pandemic vaccine to the World Health Organization in the event of a global flu outbreak, according to a company spokesman.

The offer was made during a meeting between U.N. officials, makers and other health experts to discuss how to provide vaccines to poor countries if the swine goes global. But it has not been finalized by either PLC or WHO.

On Tuesday, U.N. head Ban Ki-moon and WHO chief Margaret Chan appealed to drugmakers to save some of their pandemic vaccines for poor nations. Several vaccine makers in developing countries have also offered to share some of their vaccines, but their production capacity is limited.

Glaxo spokesman Stephen Rea said that in addition to the vaccine donation, the company will also reduce its pandemic vaccine prices for developing countries.

No pandemic vaccine exists yet, but pharmaceuticals say they can begin production immediately once they get the vaccine's key ingredient, a "seed stock" based on the virus. That is being developed by the United States' Centers for Disease Prevention and Control, and should be available by mid-July, WHO said.

Once vaccine makers receive the seed stock, a vaccine should be available in several months.

Glaxo has also signed agreements with various countries to provide them with as soon as it's available. It has promised to provide 60 million doses for Britain, 12.6 million doses for Belgium and 5.3 million doses for Finland. It is also waiting to finalize a deal with France that would provide them with 50 million vaccines.

So far, other big vaccine makers have not followed suit with offers to donate. Swiss pharma giant Novartis AG said its position remained unchanged since the question of vaccine access for poor countries first came to the fore in connection with the .

"It's pretty much the status of discussions two years ago," spokesman Eric Althoff said.

"I don't think that all of the answers are there yet."

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Vaccines tested for use against bird flu

Related Stories

Vaccines tested for use against bird flu

March 31, 2006

Human testing on a two potential vaccines against the H5N1 strain of bird flu has begun in Germany and Belgium, according to GlaxoSmithKline PLC.

Baxter signs British flu vaccine deal

August 17, 2007

Baxter International said it has entered into an agreement to supply Britain with flu vaccine in the event of a bird flu pandemic.

WHO meets on production of swine flu vaccine

May 14, 2009

(AP) -- As swine flu cases hit 6,500 worldwide, World Health Organization officials were meeting with vaccine manufacturers and other experts in Geneva on Thursday to discuss making a vaccine to fight the virus.

GlaxoSmithKline taking pandemic vaccine orders

May 15, 2009

(AP) -- Pharmaceutical giant GlaxoSmithKline said Friday it has received orders from several countries to stockpile pandemic vaccine as soon as it gets the vaccine's key ingredient from the World Health Organization.

WHO: No swine flu vaccine available for months (Update)

May 19, 2009

(AP) -- Drug manufacturers won't be able to start making a swine flu vaccine until mid-July at the earliest, weeks later than previous predictions, the World Health Organization said Tuesday. It will then take months to ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.